| Product Code: ETC7746909 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, Japan continued to rely on various countries for its pyruvate kinase imports, with China, Denmark, Germany, USA, and Taiwan, Province of China leading the way. Despite the competition, the market maintained a low concentration level, indicating a diverse import landscape. The compound annual growth rate (CAGR) from 2020 to 2024 stood at a steady 3.29%, although there was a slight decline in growth from 2023 to 2024 at -2.27%. These figures suggest a stable market with room for potential shifts in the coming years.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Japan Pyruvate Kinase Market Overview |
3.1 Japan Country Macro Economic Indicators |
3.2 Japan Pyruvate Kinase Market Revenues & Volume, 2021 & 2031F |
3.3 Japan Pyruvate Kinase Market - Industry Life Cycle |
3.4 Japan Pyruvate Kinase Market - Porter's Five Forces |
3.5 Japan Pyruvate Kinase Market Revenues & Volume Share, By Drugs, 2021 & 2031F |
4 Japan Pyruvate Kinase Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of pyruvate kinase deficiency in Japan |
4.2.2 Growing awareness about the importance of early diagnosis and treatment of pyruvate kinase disorders |
4.2.3 Technological advancements in diagnostic tools and treatment options for pyruvate kinase disorders |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of pyruvate kinase deficiency treatments |
4.3.2 Limited availability of specialized healthcare facilities for the diagnosis and treatment of pyruvate kinase disorders in Japan |
5 Japan Pyruvate Kinase Market Trends |
6 Japan Pyruvate Kinase Market, By Types |
6.1 Japan Pyruvate Kinase Market, By Drugs |
6.1.1 Overview and Analysis |
6.1.2 Japan Pyruvate Kinase Market Revenues & Volume, By Drugs, 2021- 2031F |
6.1.3 Japan Pyruvate Kinase Market Revenues & Volume, By Pyrukynd (Mitapivat), 2021- 2031F |
6.1.4 Japan Pyruvate Kinase Market Revenues & Volume, By RPL301, 2021- 2031F |
7 Japan Pyruvate Kinase Market Import-Export Trade Statistics |
7.1 Japan Pyruvate Kinase Market Export to Major Countries |
7.2 Japan Pyruvate Kinase Market Imports from Major Countries |
8 Japan Pyruvate Kinase Market Key Performance Indicators |
8.1 Number of research studies and clinical trials focused on pyruvate kinase disorders in Japan |
8.2 Adoption rate of advanced diagnostic tools for pyruvate kinase deficiency in healthcare facilities |
8.3 Rate of early diagnosis of pyruvate kinase disorders in Japan |
9 Japan Pyruvate Kinase Market - Opportunity Assessment |
9.1 Japan Pyruvate Kinase Market Opportunity Assessment, By Drugs, 2021 & 2031F |
10 Japan Pyruvate Kinase Market - Competitive Landscape |
10.1 Japan Pyruvate Kinase Market Revenue Share, By Companies, 2024 |
10.2 Japan Pyruvate Kinase Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |